4.4 Article

Development of a New Method for Genetic Transformation of the Green Alga Chlorella ellipsoidea

Journal

MOLECULAR BIOTECHNOLOGY
Volume 54, Issue 2, Pages 211-219

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12033-012-9554-3

Keywords

Chlorella ellipsoidea; Green algae; New transformation method; Cell wall-degrading enzyme; Cellulase; Plasmid DNA; Beta-glucuronidase (GUS); Bacterial ble gene

Funding

  1. National Science Foundation of China [31172029]
  2. Tianjin Foundation for Science [07JCYBJC15400]

Ask authors/readers for more resources

Chlorella ellipsoidea is a single-celled eukaryotic green microalgae with high nutritional value. Its value may be further increased if a simple, reliable and cost-effective transformation method for C. ellipsoidea can be developed. In this paper, we describe a novel transformation method for C. ellipsoidea . This system is based on treatment of C. ellipsoidea cells with cellulolytic enzymes to weaken their cell walls, making them become competent to take up foreign DNA. To demonstrate the usefulness and effectiveness of this method, we treated C. ellipsoidea cells with a cell wall-degrading enzyme, cellulase, followed by transformation with plasmid pSP-Ubi-GUS harbouring both the zeocin resistance gene and the beta-glucuronidase (GUS) reporter gene that serve as selective makers for transformation. Transformants were readily obtained on zeocin selection medium, reaching transformation efficiency of 2.25 x 10(3) transformants/mu g of plasmid DNA. PCR analysis has also demonstrated the presence of the GUS reporter gene in the zeocin-resistant transformants. Histochemical assays further showed the expression of the GUS activity in both primary transformants and transformants after long-term growth (10 months) with antibiotic selection on and off. Availability of a simple and efficient transformation system for C. ellipsoidea will accelerate the exploration of this microalga for a broader range of biotechnological applications, including its use as a biologic factory for the production of high-value human therapeutic proteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available